Related Experiment Video

Updated: Aug 16, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Biomarkers in angina

Paul O Collinson1

  • 1Dept Chemical Pathology, Cardiology, St George's Hospital and Medical School, London, UK.

Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|August 23, 2005
PubMed

Insights

Atherothrombotic disease, starting as angina, can lead to myocardial infarction. Biomarkers like B-type natriuretic peptide and ischemia-modified albumin show promise for predicting cardiac events and early ischemia detection.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomarker Research

Background:

  • Angina is the initial symptomatic stage of atherothrombotic disease, preceding myocardial infarction.
  • Plaque development is linked to traditional risk factors, with progression driven by plaque destabilization and rupture.
  • Inflammatory markers like C-reactive protein predict cardiac events, but B-type natriuretic peptide is a potent predictor of cardiovascular mortality.

Purpose of the Study:

  • To review the continuum of atherothrombotic disease from angina to myocardial infarction.
  • To highlight the role of inflammatory markers and peptide hormones in disease progression and risk stratification.
  • To identify promising biomarkers for early detection of myocardial ischemia.

Main Methods:

  • Literature review of atherothrombotic disease progression.
  • Analysis of the predictive value of inflammatory markers and cardiac biomarkers.
  • Evaluation of emerging markers for ischemia detection.

Main Results:

  • B-type natriuretic peptide is identified as the most powerful predictor of cardiovascular mortality, reflecting its role in cardiac neuroendocrine integration.
  • Ischemia-modified albumin shows potential as a marker for early ischemia detection upon presentation.
  • The progression from plaque rupture to myocardial ischemia and infarction is a continuous process.

Conclusions:

  • Understanding the continuum of atherothrombotic disease is crucial for risk stratification and intervention.
  • Biomarkers play a key role in predicting cardiovascular events and guiding clinical management.
  • Ischemia-modified albumin represents a promising avenue for early diagnosis of myocardial ischemia.

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Related Concept Videos

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...